[ad_1]
The federal government has purchased a new corona antibody-based drug for Germany. »From next week, monoclonal antibodies will be used in Germany as the first EU country. First in university clinics, “said Federal Health Minister Jens Spahn (CDU) of” Bild am Sonntag. “” The federal government bought 200,000 cans for 400 million euros, “said Spahn.
The then President of the United States, Donald Trump, was treated with this form of antibodies after his corona infection. “They act like a passive vaccine. Administering these antibodies can help early-stage high-risk patients prevent a severe course, ”says Spahn.
The antibody cocktail that Trump received shortly after his diagnosis is made by the American biotech company Regeneron. It contains two antibodies that are directed against a key Sars-CoV-2 protein.
In therapy with the agent, patients receive artificially generated antibodies that are supposed to bind to the coronavirus and prevent it from entering cells. The virus can only multiply there. For this reason, antibody therapies are linked to two different hopes.
For one thing, they are supposed to protect infected people from serious diseases. In addition, they can also protect healthy people from infections and therefore can be used by doctors and nurses until they are vaccinated.
